Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
of immune cells as key regulators of the tumor microenvironment. Collaboration with pathologists for tissue imaging correlations and with computational biologists is expected. The work will largely involve
-
either experimental or computational in nature, or both, are encouraged to apply. Key duties of the role may include: Focussing on common diseases. Challenging orthodox approaches and innovate. Driving
-
programme designated to attract and empower the world’s brightest early-career researchers. This fellowship supports outstanding scientists who harness Artificial Intelligence (AI) to accelerate breakthroughs
-
are available from 1 July 2025 to 30 June 2026 in the first instance. Based in the interdisciplinary Living Systems Institute, the successful applicants will join a world-leading programme of investigations
-
, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability, age, ancestry, military service, protected veteran status, or other characteristics
-
and experimental strategies. Qualifications Ph.D. in Cancer Biology, Molecular Biology, Genetics, or a related field. Extensive experience in molecular biology techniques, including cloning and genome
-
qualified applicant to receive consideration for employment without regard to race, color, religion, sex, gender identity or expression, national origin, sexual orientation, genetic information, disability
-
to candidates with a strong quantitative background. We welcome applicants with training in mathematics, statistics, health economics, computer science, or epidemiology, particularly those with good numeracy and
-
Postdoctoral Fellow – Mitochondrial Microproteins & Therapeutic Innovation Lena Ho Lab | Duke-NUS Medical School, Singapore Cardiovascular & Metabolic Disorders Programme Advance scientific
-
of lncRNAs with various proteins, lipids and microRNAs etc. Research platforms in the laboratory include human embryonic stem (ES) cells, patient-derived induced pluripotent stem (iPS) cells, mouse genetic